Which Organisms Can Be Bloodborne Pathogens?

Bloodborne pathogens span nearly every major category of infectious agent, from viruses and bacteria to protozoan parasites, fungi, multicellular worms, and even misfolded proteins called prions. A diagnostic microarray designed to screen donated blood was built to detect 97 distinct bloodborne pathogens in a single test, covering viral, bacterial, and protozoan organisms alike. That number only hints at the true breadth: some of these organisms have evolved intricate ways to live inside red blood cells for weeks, while others simply pass through the bloodstream on their way to other tissues. The range of life forms that have figured out how to exploit human blood is wider than most people realize, and the strategies they use are strikingly different.

Viruses and the Blood Supply

Viruses are the bloodborne pathogens most people think of first, and for good reason. Hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV are the three that dominate public health screening programs, workplace safety protocols, and blood bank testing worldwide. All three share a crucial trait: they can persist in the blood for months or years, creating a long window during which transmission is possible through needlesticks, transfusions, or shared injection equipment.

HBV is a particularly impressive survivor. During active replication, it floods the blood with enormous viral loads and a massive surplus of surface antigen particles, all without killing the liver cells it infects.¹ HCV takes a different approach, using escape mutations, growth at sites sheltered from immune surveillance, and direct antagonism of the host’s virus-fighting machinery to establish chronic infection.² Both viruses can circulate in someone who feels perfectly healthy, which is exactly what makes them dangerous in blood donation and occupational exposure settings.

Beyond the “big three,” a growing list of viruses turn up in the blood of apparently healthy donors. A metagenomic study of donated blood found that among viral sequences detected, cytomegalovirus accounted for roughly two-thirds, followed by hepatitis E virus and members of the Anelloviridae family, including torque teno virus.³ Cytomegalovirus is common enough in the general population that its presence is almost expected, but hepatitis E is a reminder that screening panels can lag behind reality.

Arboviruses as Short-Term Bloodborne Threats

Not all bloodborne viruses set up long-term residence. Arboviruses, which depend on arthropod vectors like mosquitoes and ticks for their natural transmission cycle, produce a temporary burst of virus in the blood called viremia.⁴ That window is short, sometimes only a few days, but it is enough to pose a risk through blood transfusion or needlestick injury.

Chikungunya virus illustrates this well. Researchers measuring viral loads in people with chikungunya found that even asymptomatic individuals carried detectable virus in their blood, raising the question of whether they could unknowingly pass the infection along through a blood donation.⁵ Dengue, Zika, and West Nile virus present the same concern. Blood banks in endemic areas now screen for some of these viruses, but the list of arboviruses capable of being bloodborne keeps growing as surveillance improves.

Bacteria in the Bloodstream

Bacteria are not traditionally thought of as bloodborne pathogens in the same way viruses are, partly because the immune system is generally fast and aggressive in clearing bacteria from the blood. The complement system, a collection of proteins that circulates in plasma, can recognize bacteria, tag them for destruction, or kill them outright by punching holes in their membranes.⁶ But some bacteria have evolved sophisticated ways around these defenses.

One striking example is Bartonella, the group of bacteria behind cat scratch disease, trench fever, and several other illnesses. Bartonella species can invade red blood cells, replicate inside them, and persist in the bloodstream for weeks. Red blood cells lack the internal machinery to present foreign proteins to the immune system, so once Bartonella gets inside, it is effectively hidden.⁷ This is an unusual trick for a bacterium: most bacteria that enter the blood either get cleared quickly or cause overwhelming sepsis. Bartonella has carved out a middle path, persisting at low levels without necessarily making the host acutely ill.

The metagenomic study of healthy donor blood also turned up bacterial sequences, with Escherichia coli dominating the findings. Whether these represent true bloodstream infections, transient passage of gut bacteria, or even contamination during sample handling is often hard to pin down.³ Treponema pallidum, the spirochete that causes syphilis, is another well-established bacterial bloodborne pathogen. It circulates in the blood during early stages of infection and can be transmitted through transfusion, which is why syphilis screening remains standard for donated blood.

Protozoan Parasites

Some of the most clinically devastating bloodborne pathogens are single-celled parasites. Malaria, caused by Plasmodium species, is the most consequential. Plasmodium parasites specifically target red blood cells, invading them by engaging surface receptors and then physically penetrating the cell membrane using their own molecular motor.⁸ Once inside, the parasite feeds on hemoglobin, multiplies, and eventually bursts out to invade fresh red blood cells. This cycle of invasion and destruction is what produces the classic waves of fever and anemia in malaria patients.

Babesia microti, a tick-transmitted parasite found primarily in the northeastern and upper midwestern United States, is another intraerythrocytic pathogen. It is responsible for the majority of transfusion-transmitted babesiosis cases in the U.S., and its presence has prompted the development of specific donor screening programs.⁹ Babesia looks superficially like malaria under a microscope, since both form ring-shaped structures inside red blood cells, but it belongs to a completely different branch of parasitology.

Trypanosoma cruzi, the cause of Chagas disease, and Trypanosoma brucei, the cause of African sleeping sickness, are also bloodborne. T. cruzi can circulate in the blood during its acute phase and has been documented in transfusion-transmitted cases, particularly in Latin America and among immigrants to non-endemic countries. Leishmania species, which cause a spectrum of diseases from skin ulcers to life-threatening organ infection, have also been detected in donor blood. In the metagenomic study of healthy donors, Toxoplasma gondii and Leishmania infantum were among the most frequently identified parasite sequences, alongside Plasmodium falciparum.³

Fungi That Thrive in Blood

Fungal bloodstream infections, known as fungemia, are less common in healthy people but are a serious threat to anyone with a weakened immune system. Candida species are the most frequent fungal bloodborne pathogens, and research into how they survive in blood has revealed something interesting: different Candida species use entirely different metabolic strategies and virulence tools to cope with the hostile environment of the bloodstream. Their ability to survive in blood is not something they inherited from a shared ancestor but appears to have evolved independently in each species.¹⁰

This convergent evolution underscores just how strong the selective pressure is. Blood is nutrient-rich, but it is also packed with immune cells and antimicrobial proteins. Any organism that can survive there gains access to every organ in the body. For Candida, this often means dissemination from a catheter site or the gut into the bloodstream, followed by seeding of the kidneys, eyes, heart valves, or brain. Cryptococcus neoformans, the yeast that causes cryptococcal meningitis, and Histoplasma capsulatum, which causes a systemic infection after being inhaled from contaminated soil, can also circulate in the blood. All of these are opportunistic in the sense that a healthy immune system usually prevents them from reaching the bloodstream, but once there, they are genuine bloodborne pathogens.

Multicellular Parasites in the Blood

The idea that a worm could live inside your blood vessels sounds like science fiction, but schistosomes do exactly that. Adult schistosome worms, which can be a centimeter or more in length, live inside the veins surrounding the intestines or bladder, feeding on blood and producing eggs for years. Their survival depends on an extraordinary ability to evade the immune system despite being physically present in the vasculature. The worms accomplish this through changes to their outer surface that reduce their visibility to immune cells, combined with a tegument that is intrinsically resistant to immune-mediated damage.¹¹

Filarial worms present a different pattern. The adult worms of species like Wuchereria bancrofti and Brugia malayi live in the lymphatic system, but their larval stage, called microfilariae, circulates in the bloodstream. These microscopic larvae are adapted to survive in blood for months while they wait to be picked up by a mosquito. Because microfilariae are present in the peripheral blood, filarial infections can theoretically be transmitted by transfusion, and they certainly show up in blood smears from infected individuals. Loa loa, the African eye worm, also releases microfilariae that circulate in the blood with a striking periodicity, peaking during daytime hours to coincide with the biting habits of their fly vector.

Prions as an Unconventional Bloodborne Agent

Prions are not organisms in any traditional sense. They are misfolded versions of a normal brain protein that can force other copies of that protein to misfold, causing progressive, always-fatal brain degeneration. But the variant form of Creutzfeldt-Jakob disease (vCJD), linked to mad cow disease, has been transmitted through blood transfusion. In the United Kingdom, where the vCJD outbreak was concentrated, the likelihood of transmission to a recipient who received blood from a donor who later developed vCJD was estimated at about 14% for recipients surviving more than five years after the transfusion.¹²

Animal studies have helped clarify the mechanics. In sheep experimentally infected with BSE (the bovine equivalent of vCJD), all types of blood components, including red blood cells, platelets, and plasma, were capable of transmitting prion disease when donors were still in the preclinical phase with no visible symptoms. Removing white blood cells from blood products significantly reduced transmission rates but did not eliminate them entirely.¹³ A separate sheep study found unexpectedly high overall transfusion transmission rates of 36% for BSE and 43% for scrapie, with some infected recipients surviving for years without clinical signs.¹⁴

Classic CJD, the sporadic form unrelated to mad cow disease, has never been documented to spread through blood transfusion, and epidemiological studies have found no evidence that it does.¹² The distinction matters: vCJD and classic CJD appear to behave very differently in the blood. This is part of why prion diseases remain so tricky for blood safety programs, since there is no routine screening test for prions in donated blood, and risk is managed primarily through donor deferral policies and white blood cell removal.

How Bloodborne Pathogens Feed and Hide

One of the common threads across these wildly different organisms is the need to acquire iron. Human blood is iron-rich, but the body goes to considerable lengths to keep iron locked up in proteins like transferrin and hemoglobin, precisely because so many pathogens need it. Bacteria and fungi have responded by evolving a shared toolkit: they produce iron-scavenging molecules called siderophores, they strip iron from hemoglobin and transferrin, and some can chemically reduce iron to a form they can absorb more easily.¹⁵ The parallel evolution of these strategies in completely unrelated organisms tells you something about how fierce the competition for iron is in the bloodstream.

Immune evasion is the other universal requirement. The specific strategies vary enormously. Plasmodium remodels the surface of the red blood cell it occupies, displaying proteins that change with each generation to stay ahead of antibodies. Schistosomes cloak themselves in host molecules. HCV sabotages the T cells sent to destroy it. Bartonella hides inside red blood cells that lack the ability to sound an immune alarm. The common denominator is that no organism survives long in the blood without a way to avoid or suppress the immune response. Organisms that end up in the bloodstream without such adaptations, like most gut bacteria that occasionally slip through a damaged intestinal lining, are typically cleared within hours.

Survival Outside the Body

How long a bloodborne pathogen remains infectious on surfaces or in discarded equipment matters for real-world exposure risk. HBV is notoriously tough. In laboratory testing, HBV remained fully infectious after 28 days at room temperature, with only about a 10% drop in infectivity. Stored at refrigerator temperature, the virus held steady for six months, and even after nine months it was still detectable well above the minimum infectious threshold.¹⁶ This is why HBV transmission from contaminated surfaces, shared razors, or improperly sterilized medical equipment is a genuine concern even when the blood is not visibly fresh.

HCV is less hardy but still dangerous. Researchers testing syringes contaminated with HCV-spiked plasma found recoverable virus after three days at room temperature, with the amount varying up to sixfold depending on the syringe and needle design.¹⁷ The dead space inside a needle, the small volume of fluid trapped at the hub, is where the virus survives longest. This finding has direct relevance for people who inject drugs and for needle-exchange program design. HIV, by contrast, is relatively fragile outside the body and is quickly inactivated by drying, though it can survive longer in larger volumes of blood or inside a syringe.

Medical Devices and the Gut-to-Blood Route

Some organisms become bloodborne not through classic infection routes but through medical interventions. Central venous catheters, the large intravenous lines used in hospitals for chemotherapy, nutrition, or monitoring, are a major entry point. Bacteria and fungi colonize the catheter surface and form biofilms, structured communities encased in a protective matrix that shields them from both antibiotics and immune cells. Once established, these biofilms can continuously shed organisms into the bloodstream.¹⁸ Catheter-related bloodstream infections are one of the most common hospital-acquired infections, and the organisms responsible, typically Staphylococcus species and Candida, are bloodborne pathogens by virtue of the device rather than by any particular adaptation to the blood.

There is also growing recognition that the gut itself is a source of bloodborne bacteria under certain conditions. When the intestinal barrier breaks down, whether from chronic inflammation, obesity-related metabolic changes, or critical illness, bacteria from the gut can cross into the bloodstream. This process, called bacterial translocation, involves the depletion of beneficial gut microbes and the weakening of the molecular seals between intestinal lining cells, allowing proinflammatory bacteria to leak through.¹⁹ The resulting low-grade bacteremia is different from a classical bloodstream infection, but it represents another way organisms end up in the blood.

Blood Safety Technologies and Their Limits

Modern pathogen reduction technologies applied to donated blood products can inactivate viruses, bacteria, parasites, and even residual white blood cells that might carry intracellular infections.²⁰ These systems work broadly, using UV light or chemical agents that damage nucleic acids, so they do not need to be redesigned every time a new pathogen emerges. But they are not universal solutions. Prions contain no nucleic acids at all, so they are invisible to these technologies. Red blood cell concentrates, which are the most commonly transfused blood product, still cannot be treated with most pathogen reduction platforms without unacceptable damage to the cells themselves.

The sheer diversity of organisms that can enter the blood, from a virus a few nanometers across to a worm centimeters long, from a self-replicating bacterium to a misfolded protein with no genome, means that no single screening test or inactivation method covers everything. Blood safety relies on layered defenses: donor questionnaires to catch risk factors, serological and nucleic acid testing for specific known threats, pathogen reduction where applicable, and epidemiological surveillance to flag emerging agents before they become entrenched. Each layer catches some things and misses others, and the list of organisms capable of circulating in human blood is long enough to ensure that the work of closing gaps never quite finishes.

When Healthy Blood Is Not Sterile

A persistent assumption in medicine has been that blood in a healthy person is sterile, containing no living microorganisms. That view is shifting. The metagenomic screening of apparently healthy blood donors found sequences from bacteria, viruses, and parasites across a large fraction of samples, with parasitic sequences alone accounting for nearly half of all microbial reads detected.³ Whether all of these represent genuinely viable organisms, as opposed to fragments of DNA from dead microbes that wandered through the gut lining, remains debated. But the detection of sequences from organisms like Toxoplasma gondii and cytomegalovirus in people who passed routine health screenings suggests that subclinical carriage of bloodborne organisms may be more common than the textbook model of sterile blood implies. For blood banking, this means that “healthy donor” is not synonymous with “pathogen-free blood,” and that emerging detection technologies will likely continue to expand the roster of organisms we know can be found circulating in the human bloodstream.